1-(1H-benzimidazol-2-yl)-N-benzylmethanimine;N-benzyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-benzyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;N-(5-tert-butyl-2-methoxyphenyl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2-methoxyphenyl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine;N-(2-methoxyphenyl)-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine

C208H176F6N26O3 — CID 161141252

About 1-(1H-benzimidazol-2-yl)-N-benzylmethanimine;N-benzyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-benzyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;N-(5-tert-butyl-2-methoxyphenyl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2-methoxyphenyl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine;N-(2-methoxyphenyl)-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine

1-(1H-benzimidazol-2-yl)-N-benzylmethanimine;N-benzyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-benzyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;N-(5-tert-butyl-2-methoxyphenyl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2-methoxyphenyl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine;N-(2-methoxyphenyl)-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine (PubChem CID 161141252) has the molecular formula C208H176F6N26O3 and a molecular weight of 3201.86 g/mol. Its IUPAC name is 1-(1H-benzimidazol-2-yl)-N-benzylmethanimine;N-benzyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-benzyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;N-(5-tert-butyl-2-methoxyphenyl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2-methoxyphenyl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine;N-(2-methoxyphenyl)-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine.

Molecular Properties

• Compound Name: 1-(1H-benzimidazol-2-yl)-N-benzylmethanimine;N-benzyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-benzyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;N-(5-tert-butyl-2-methoxyphenyl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2-methoxyphenyl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine;N-(2-methoxyphenyl)-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine
• PubChem CID: 161141252
• Molecular Formula: C208H176F6N26O3
• Molecular Weight: 3201.86 g/mol
• Exact Mass: 3199.43
• IUPAC Name: 1-(1H-benzimidazol-2-yl)-N-benzylmethanimine;N-benzyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-benzyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;N-(5-tert-butyl-2-methoxyphenyl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2-methoxyphenyl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine;N-(2-methoxyphenyl)-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine
• SMILES: C(=N/Cc1ccccc1)\c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1.C(=N/Cc1ccccc1)\c1nc2ccccc2[nH]1.COc1ccc(C(C)(C)C)cc1/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2n1C.COc1ccccc1/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1.COc1ccccc1/N=C/c1nc2ccccc2n1C.Cn1c(/C=N/Cc2ccccc2)nc2c(-c3ccccc3)ccc(-c3ccccc3)c21.Cn1c(/C=N/c2cc(C(F)(F)F)ccc2N2CCCC2)nc2c(-c3ccccc3)ccc(-c3ccccc3)c21.FC(F)(F)c1ccc(N2CCCC2)c(/N=C/c2nc3c(-c4ccccc4)ccc(-c4ccccc4)c3[nH]2)c1
• InChI: InChI=1S/C32H27F3N4.C32H31N3O.C31H25F3N4.C28H23N3.C27H21N3O.C27H21N3.C16H15N3O.C15H13N3/c1-38-29(21-36-27-20-24(32(33,34)35)14-17-28(27)39-18-8-9-19-39)37-30-25(22-10-4-2-5-11-22)15-16-26(31(30)38)23-12-6-3-7-13-23;1-32(2,3)24-16-19-28(36-5)27(20-24)33-21-29-34-30-25(22-12-8-6-9-13-22)17-18-26(31(30)35(29)4)23-14-10-7-11-15-23;32-31(33,34)23-13-16-27(38-17-7-8-18-38)26(19-23)35-20-28-36-29-24(21-9-3-1-4-10-21)14-15-25(30(29)37-28)22-11-5-2-6-12-22;1-31-26(20-29-19-21-11-5-2-6-12-21)30-27-24(22-13-7-3-8-14-22)17-18-25(28(27)31)23-15-9-4-10-16-23;1-31-24-15-9-8-14-23(24)28-18-25-29-26-21(19-10-4-2-5-11-19)16-17-22(27(26)30-25)20-12-6-3-7-13-20;1-4-10-20(11-5-1)18-28-19-25-29-26-23(21-12-6-2-7-13-21)16-17-24(27(26)30-25)22-14-8-3-9-15-22;1-19-14-9-5-3-7-12(14)18-16(19)11-17-13-8-4-6-10-15(13)20-2;1-2-6-12(7-3-1)10-16-11-15-17-13-8-4-5-9-14(13)18-15/h2-7,10-17,20-21H,8-9,18-19H2,1H3;6-21H,1-5H3;1-6,9-16,19-20H,7-8,17-18H2,(H,36,37);2-18,20H,19H2,1H3;2-18H,1H3,(H,29,30);1-17,19H,18H2,(H,29,30);3-11H,1-2H3;1-9,11H,10H2,(H,17,18)/b36-21+;33-21+;35-20+;29-20+;28-18+;28-19+;17-11+;16-11+
• InChIKey: UNLZBBQAUHYMTL-XWKHYEDCSA-N
• XLogP: 50.72
• TPSA: 319.05 Ų
• H-Bond Donors: 4
• H-Bond Acceptors: 25
• Rotatable Bonds: 36
• Heavy Atoms: 243
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	3201.86
LogP ≤ 5	50.72
H-Bond Donors ≤ 5	4
H-Bond Acceptors ≤ 10	25

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'imine_1', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 1-(1H-benzimidazol-2-yl)-N-benzylmethanimine;N-benzyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-benzyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;N-(5-tert-butyl-2-methoxyphenyl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2-methoxyphenyl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine;N-(2-methoxyphenyl)-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine?

The IUPAC name of 1-(1H-benzimidazol-2-yl)-N-benzylmethanimine;N-benzyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-benzyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;N-(5-tert-butyl-2-methoxyphenyl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2-methoxyphenyl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine;N-(2-methoxyphenyl)-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine (CID 161141252) is 1-(1H-benzimidazol-2-yl)-N-benzylmethanimine;N-benzyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-benzyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;N-(5-tert-butyl-2-methoxyphenyl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2-methoxyphenyl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine;N-(2-methoxyphenyl)-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine.

What is the SMILES notation for 1-(1H-benzimidazol-2-yl)-N-benzylmethanimine;N-benzyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-benzyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;N-(5-tert-butyl-2-methoxyphenyl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2-methoxyphenyl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine;N-(2-methoxyphenyl)-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine?

The canonical SMILES for 1-(1H-benzimidazol-2-yl)-N-benzylmethanimine;N-benzyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-benzyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;N-(5-tert-butyl-2-methoxyphenyl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2-methoxyphenyl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine;N-(2-methoxyphenyl)-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine is C(=N/Cc1ccccc1)\c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1.C(=N/Cc1ccccc1)\c1nc2ccccc2[nH]1.COc1ccc(C(C)(C)C)cc1/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2n1C.COc1ccccc1/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1.COc1ccccc1/N=C/c1nc2ccccc2n1C.Cn1c(/C=N/Cc2ccccc2)nc2c(-c3ccccc3)ccc(-c3ccccc3)c21.Cn1c(/C=N/c2cc(C(F)(F)F)ccc2N2CCCC2)nc2c(-c3ccccc3)ccc(-c3ccccc3)c21.FC(F)(F)c1ccc(N2CCCC2)c(/N=C/c2nc3c(-c4ccccc4)ccc(-c4ccccc4)c3[nH]2)c1.

What is the InChIKey of 1-(1H-benzimidazol-2-yl)-N-benzylmethanimine;N-benzyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-benzyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;N-(5-tert-butyl-2-methoxyphenyl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2-methoxyphenyl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine;N-(2-methoxyphenyl)-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine?

The InChIKey is UNLZBBQAUHYMTL-XWKHYEDCSA-N. The full InChI is InChI=1S/C32H27F3N4.C32H31N3O.C31H25F3N4.C28H23N3.C27H21N3O.C27H21N3.C16H15N3O.C15H13N3/c1-38-29(21-36-27-20-24(32(33,34)35)14-17-28(27)39-18-8-9-19-39)37-30-25(22-10-4-2-5-11-22)15-16-26(31(30)38)23-12-6-3-7-13-23;1-32(2,3)24-16-19-28(36-5)27(20-24)33-21-29-34-30-25(22-12-8-6-9-13-22)17-18-26(31(30)35(29)4)23-14-10-7-11-15-23;32-31(33,34)23-13-16-27(38-17-7-8-18-38)26(19-23)35-20-28-36-29-24(21-9-3-1-4-10-21)14-15-25(30(29)37-28)22-11-5-2-6-12-22;1-31-26(20-29-19-21-11-5-2-6-12-21)30-27-24(22-13-7-3-8-14-22)17-18-25(28(27)31)23-15-9-4-10-16-23;1-31-24-15-9-8-14-23(24)28-18-25-29-26-21(19-10-4-2-5-11-19)16-17-22(27(26)30-25)20-12-6-3-7-13-20;1-4-10-20(11-5-1)18-28-19-25-29-26-23(21-12-6-2-7-13-21)16-17-24(27(26)30-25)22-14-8-3-9-15-22;1-19-14-9-5-3-7-12(14)18-16(19)11-17-13-8-4-6-10-15(13)20-2;1-2-6-12(7-3-1)10-16-11-15-17-13-8-4-5-9-14(13)18-15/h2-7,10-17,20-21H,8-9,18-19H2,1H3;6-21H,1-5H3;1-6,9-16,19-20H,7-8,17-18H2,(H,36,37);2-18,20H,19H2,1H3;2-18H,1H3,(H,29,30);1-17,19H,18H2,(H,29,30);3-11H,1-2H3;1-9,11H,10H2,(H,17,18)/b36-21+;33-21+;35-20+;29-20+;28-18+;28-19+;17-11+;16-11+.

What are the key properties of 1-(1H-benzimidazol-2-yl)-N-benzylmethanimine;N-benzyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-benzyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;N-(5-tert-butyl-2-methoxyphenyl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2-methoxyphenyl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine;N-(2-methoxyphenyl)-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine?

1-(1H-benzimidazol-2-yl)-N-benzylmethanimine;N-benzyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-benzyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;N-(5-tert-butyl-2-methoxyphenyl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2-methoxyphenyl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine;N-(2-methoxyphenyl)-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine has a molecular weight of 3201.86 g/mol, XLogP of 50.72, 36 rotatable bonds, 4 hydrogen bond donors, and 25 hydrogen bond acceptors.

Where does this data come from?

All data for 1-(1H-benzimidazol-2-yl)-N-benzylmethanimine;N-benzyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-benzyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;N-(5-tert-butyl-2-methoxyphenyl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2-methoxyphenyl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine;N-(2-methoxyphenyl)-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]methanimine is sourced from PubChem (CID 161141252), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).